Carolyn Muller is an Oncology physician affiliated with University of New Mexico. OpenAlex indexes 17 publications with 484 citations (h-index 5); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1201 Camino De Salud NE
Msc 07 4025
Albuquerque, NM 871310001
Telephone
505-925-0460Provider last certified this registry record 26 Sept 2024.
Clinical trials
- Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Sponsor: New Mexico Cancer Research Alliance
- Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients
Sponsor: New Mexico Cancer Research Alliance
- Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Sponsor: New Mexico Cancer Research Alliance
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20252 payments
- GlaxoSmithKline, LLC.Program year20233 payments
- Seagen Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Corticosteroid100%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2014–2025 per NIH RePORTER. The latest:
- The NCI Community Oncology Research Program: The New Mexico NCORP
University of New Mexico Health Scis Ctr
FY2025$1,589,898UG1CA189856 - Clinical Protocol and Data Management
University of New Mexico Health Scis Ctr
FY2025$175,491P30CA118100 - NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
University of New Mexico Health Scis Ctr
FY2024$1,586,915UG1CA189856
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Overall survival subgroup analyses for prior taxane use in the phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel versus nab-paclitaxel monotherapy in patients with platinum-resistant ovarian cancer (GOG-3073, ENGOT-ov72, APGOT-Ov10, LACOG-0223, and ANZGOG-2221/2023).
Journal of Clinical Oncology
2026 - A PHASE 2 STUDY OF AVUTOMETINIB (VS-6766; DUAL RAF/MEK INHIBITOR) PLUS DEFACTINIB (FAK INHIBITOR) IN RECURRENT GYNECOLOGICAL CANCERS (DURAFAK)
International Journal of Gynecological Cancer
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Mauricio Tohen, MD, DRPH, MBA
University of New Mexico
Howard Yonas, MD
University of New Mexico
Rhoshel Lenroot, MD
University of New Mexico
Mark Unruh, MD
University of New Mexico
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”